Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients

NCT00217815 is registered in ClinicalTrials.gov with NeuTec Pharma as lead sponsor.

NCT NCT00217815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00217815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase Ib, Pharmacokinetic, Multiple Center, Open Label Study Evaluating the Safety and Efficacy of Mycograb Administered IV in Combination With Docetaxel in Metastatic or Recurrent Breast Cancer Patients
Lead sponsor
NeuTec Pharma
Phase
Phase 1/2
Overall status
Completed
Start date
September 30, 2005
Completion date
October 31, 2006
Enrollment
20
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of the breast